European Union - English - EMA (European Medicines Agency)

takeda manufacturing austria ag - human normal immunoglobulin (ivig) - purpura, thrombocytopenic, idiopathic; bone marrow transplantation; immunologic deficiency syndromes; guillain-barre syndrome; mucocutaneous lymph node syndrome - immune sera and immunoglobulins, - replacement therapy in adults, and children and adolescents (0-18 years) in:primary immunodeficiency syndromes with impaired antibody production;hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed;hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who have failed to respond to pneumococcal immunisation;hypogammaglobulinaemia in patients after allogeneic haematopoietic-stem-cell transplantation (hsct);congenital aids and recurrent bacterial infections.immunomodulation in adults, and children and adolescents (0-18 years) in:primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;guillain barré syndrome;kawasaki disease;multifocal motor neuropathy (mmn).

European Union - English - EMA (European Medicines Agency)

csl behring gmbh - human normal immunoglobulin (ivig) - purpura, thrombocytopenic, idiopathic; bone marrow transplantation; immunologic deficiency syndromes; guillain-barre syndrome; mucocutaneous lymph node syndrome - immune sera and immunoglobulins, - replacement therapy in adults, and children and adolescents (0-18 years) in:primary immunodeficiency (pid) syndromes with impaired antibody production;hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed;hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who have failed to respond to pneumococcal immunisation;hypogammaglobulinaemia in patients after allogeneic haematopoietic-stem-cell transplantation (hsct);congenital aids with recurrent bacterial infections.immunomodulation in adults, and children and adolescents (0-18 years) in:primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;guillain-barré syndrome;kawasaki disease;chronic inflammatory demyelinating polyneuropathy (cidp). only limited experience is available of use of intravenous immunoglobulins in children with cidp.

Canada - English - Health Canada

cutter med & biol, division of miles canada ltd. - immunoglobulin (human) - liquid - 50mg - immunoglobulin (human) 50mg - serums

Canada - English - Health Canada

baxter ag - immunoglobulin (human); water - kit - 5g; 100ml - immunoglobulin (human) 5g; water 100ml - serums

Canada - English - Health Canada

bayer corporation - immunoglobulin (human) - liquid - 50mg - immunoglobulin (human) 50mg - serums

Canada - English - Health Canada

talecris biotherapeutics inc - immunoglobulin (human) - solution - 50mg - immunoglobulin (human) 50mg - serums

Canada - English - Health Canada

talecris biotherapeutics inc - immunoglobulin (human) - solution - 100mg - immunoglobulin (human) 100mg - serums

Canada - English - Health Canada

talecris biotherapeutics inc - immunoglobulin (human) - solution - 5g - immunoglobulin (human) 5g - serums

Canada - English - Health Canada

talecris biotherapeutics inc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums

Canada - English - Health Canada

baxter corporation - immunoglobulin (human) - powder for solution - 0.5g - immunoglobulin (human) 0.5g - serums